Navigation Links
Aethlon Medical to Present at Source Capital Group's 2016 Disruptive Growth & Healthcare Conference on February 10, 2016
Date:2/5/2016

SAN DIEGO, Feb. 5, 2016 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), today announced that Jim Joyce, Chairman and CEO, will be presenting at Source Capital Group's 2016 Disruptive Growth & Healthcare Conference in New York, NY at 2:15 p.m. ET on Wednesday, February 10, 2016.  Mr. Joyce will also participate in an Immunotherapy Panel discussion taking place at 3:15 p.m. ET.

The presentation will be made available to the public via live audio webcast which can be accessed by visiting the investor relations section of Aethlon Medical's corporate website at http://www.aethlonmedical.com.  The webcast will be available for replay approximately one hour after the conclusion of the live event. The panel discussion will not be webcast.

Aethlon Medical will also be presenting at the BIO CEO & Investor Conference in New York, NY at 3:30 p.m. ET on Tuesday, February 9, 2016.  A webcast of the presentation can be accessed by visiting the investor relations section of Aethlon Medical's corporate website at http://www.aethlonmedical.com.

About Aethlon Medical, Inc.

Aethlon Medical creates affinity biofiltration devices to treat life-threatening diseases.  The Aethlon Hemopurifier® is a leading broad-spectrum treatment countermeasure against infectious viral pathogens.  The device, which has been successfully administered to individuals infected with HIV, Hepatitis C (HCV) and Ebola virus, is currently the subject of FDA approved clinical studies.  Aethlon is also studying the potential use of the Hemopurifier® to address exosomes secreted by tumors to promote the spread of metastasis and suppress the immune system of cancer patients.  The Company provides government contracting services to the Defense Advanced Research Projects Agency (DARPA) related to the development of a biofiltration device to treat sepsis and maintains majority ownership of Exosome Sciences, Inc., which is focused on the discovery of exosomal biomarkers to diagnose and monitor Chronic Traumatic Encephalopathy (CTE) and other neurological disorders.  Additional information can be found online at www.AethlonMedical.com or you can connect with us on Twitter, LinkedIn, Facebook and Google+.

Contacts:

Mike Smargiassi/Brad Edwards
Brainerd Communicators, Inc
212-986-6667
smarg@braincomm.com

Photo - http://photos.prnewswire.com/prnh/20090325/LA88762LOGO-b

 


'/>"/>
SOURCE Aethlon Medical, Inc.
Copyright©2016 PR Newswire.
All rights reserved


Related medicine technology :

1. Aethlon Medical Announces the Appointment of Chetan S. Shah, M.D. to its Board of Directors
2. Aethlon Medical to Present at Exosomes and Circulating Biomarkers 2013 Summit
3. Aethlon Medical Announces Launch of Exosome Sciences Subsidiary
4. Aethlon Medical Announces Dr. Douglas Taylor as Chief Scientific Officer of Exosome Sciences, Inc.
5. Aethlon Medical Announces the Appointment of Dr. Cicek Gercel-Taylor as Clinical Research Director of Exosome Sciences, Inc.
6. Aethlon Medical (AEMD) Note: Cancer Immunotherapy Article, Introduction to Dr. Douglas Taylor
7. Aethlon Medical to Present at SeeThruEquity Investor Conference
8. Aethlon Medical to Present at Biotech Showcase Investor Conference
9. Aethlon Medical and Exosome Sciences Announce the Advancement of a Broad-Spectrum Cancer Detection and Monitoring Platform
10. Aethlon Medical Receives Notice of DARPA Contract Renewal
11. Aethlon Medical Announces Dengue Virus Treatment Agreement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2019)... ... June 18, 2019 , ... The ... for patients in the Bridgeville, PA area. Understanding the crippling effects patients experience ... Wayne DiBartola and Tyler Porco offer same-day oral sedation, nitrous oxide, and IV ...
(Date:6/16/2019)... ... , ... AVIE! MedSpa and Laser Center is proud to offer Vivace™ ... for achieving dramatic improvements to the texture and tightness of skin on any area ... with tiny needles, spurring vibrant new collagen growth for a wide range of complexion ...
(Date:6/16/2019)... ... June 15, 2019 , ... ... cell clinic offering state-of-the-art treatment with cutting-edge technology, has opened. , The ... the game-changing healing capabilities of regenerative medicine. , “Using the remarkable cutting-edge ...
Breaking Medicine Technology:
(Date:6/13/2019)... Fla. (PRWEB) , ... June 13, 2019 , ... ... research company today announced that it has signed a memorandum of understanding (MOU) ... for its drug product MMJ-001 and MMJ-002. , MMJ BioPharma Cultivation will be ...
(Date:6/13/2019)... ... 13, 2019 , ... Charm Sciences, Inc. is pleased to ... by the 2019 National Conference of Interstate Milk Shipments for screening milk tankers ... BL30SEC test was validated by third party laboratories working in collaboration with the ...
(Date:6/13/2019)... ... June 13, 2019 , ... Pure Ratios, ... with cannabis delivery company, Driven Deliveries, Inc., the only publicly traded cannabis delivery ... of the population of California with overnight cannabis delivery to major thriving markets ...
(Date:6/13/2019)... ... June 13, 2019 , ... The ... present the second annual Women|Future Conference and the advisory board that ... better position themselves and their organizations in tomorrow's marketplace. , The mission of ...
(Date:6/13/2019)... ... June 13, 2019 , ... Kno2 ... today announced that Jon Elwell, the company’s CEO, has been confirmed by the ... is a non-profit health care industry alliance created to support secure, identity-proofed electronic ...
Breaking Medicine News(10 mins):